Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 296

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 296
---
 Denali Capital Global Investments LLC, which was our sponsor prior to the closing of the Business Combination. The address of the Selling Securityholder is 11 Meadow Ln, Manhasset, NY 11030. |

| (8) | The address of the Selling Securityholder is 128 Gail Dr. New Rochelle, NY 10805. |

| (9) | U.S. Tiger acted as an underwriter in the Company’s IPO and received 50,000 shares of Common Stock as deferred compensation for such underwriter services. The address of the Selling Securityholder is 437 Madison Avenue, 27th Fl., New York, NY 10022. |

| (10) | D. Boral acted as an underwriter in the Company’s IPO and received 50,000 shares of Common Stock as deferred compensation for such underwriter services. The address of the Selling Securityholder is 590 Madison Avenue, 39th Fl., New York, NY 10022. |

| (11) | Consists of (i) 554,849 shares of Common Stock purchased from Scilex Holding Company and (ii) 11,945,151 shares of Common Stock purchased from Scilex, Inc. Biconomy’s address is 1st Floor, Ellen Skelton Building, 3076 Sir Francis Drake’s Highway, Road Town, Tortola, VG1110, British Virgin Islands. |

193

PLAN OF DISTRIBUTION We are registering the issuance by us of up to an aggregate of 8,760,000 shares of Common Stock, comprised of (i) 510,000 Private Warrant Shares and (ii) 8,250,000 Public Warrants Shares. We are also registering the offer and sale from time to time by: (a) the Selling Stockholders of up to an aggregate of 203,737,349 Resale Shares, consisting of: (i) up to 2,072,500 Sponsor Shares; (ii) up to 188,554,849 Scilex Shares; and (iii) up to 510,000 Private Warrant Shares; (iv) up to 100,000 Underwriter Shares; (v) up to 12,500,000 Biconomy Resale Shares; and (b) the Selling Warrantholders of up to 510,000 Private Warrants. We will not receive any proceeds from the sale by the Selling Securityholders of the securities offered by them described in this prospectus,